Researchers showed that genetic or pharmacological inhibition of eukaryotic elongation factor-2 kinase (eEF2K) cooperated with glutamine starvation, and synergized with glutaminase inhibitors to suppress growth of diverse TNBC cell lines.
[Scientific Reports]
6807162 {6807162:PNIIUQ2Z} apa 50 1 161687 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2f41f946405e46273e29bc985a381c3f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22PNIIUQ2Z%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ju%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJu%2C%20Y.%2C%20Ben-David%2C%20Y.%2C%20Rotin%2C%20D.%2C%20%26amp%3B%20Zacksenhaus%2C%20E.%20%282021%29.%20Inhibition%20of%20eEF2K%20synergizes%20with%20glutaminase%20inhibitors%20or%204EBP1%20depletion%20to%20suppress%20growth%20of%20triple-negative%20breast%20cancer%20cells.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%209181.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-88816-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-88816-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DPNIIUQ2Z%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Inhibition%20of%20eEF2K%20synergizes%20with%20glutaminase%20inhibitors%20or%204EBP1%20depletion%20to%20suppress%20growth%20of%20triple-negative%20breast%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22YoungJun%22%2C%22lastName%22%3A%22Ju%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yaacov%22%2C%22lastName%22%3A%22Ben-David%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Rotin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eldad%22%2C%22lastName%22%3A%22Zacksenhaus%22%7D%5D%2C%22abstractNote%22%3A%22The%20eukaryotic%20elongation%20factor-2%20kinase%2C%20eEF2K%2C%20which%20restricts%20protein%20translation%20elongation%2C%20has%20been%20identified%20as%20a%20potential%20therapeutic%20target%20for%20diverse%20types%20of%20malignancies%20including%20triple%20negative%20breast%20cancer%20%28TNBC%29.%20However%2C%20the%20contexts%20in%20which%20eEF2K%20inhibition%20is%20essential%20in%20TNBC%20and%20its%20consequences%20on%20the%20proteome%20are%20largely%20unknown.%20Here%20we%20show%20that%20genetic%20or%20pharmacological%20inhibition%20of%20eEF2K%20cooperated%20with%20glutamine%20%28Gln%29%20starvation%2C%20and%20synergized%20with%20glutaminase%20%28GLS1%29%20inhibitors%20to%20suppress%20growth%20of%20diverse%20TNBC%20cell%20lines.%20eEF2K%20inhibition%20also%20synergized%20with%20depletion%20of%20eukaryotic%20translation%20initiation%20factor%204E-binding%20protein%201%20%28eIF4EBP1%3B%204EBP1%29%2C%20a%20suppressor%20of%20eukaryotic%20protein%20translation%20initiation%20factor%204E%20%28eIF4E%29%2C%20to%20induce%20c-MYC%20and%20Cyclin%20D1%20expression%2C%20yet%20attenuate%20growth%20of%20TNBC%20cells.%20Proteomic%20analysis%20revealed%20that%20whereas%20eEF2K%20depletion%20alone%20uniquely%20induced%20Cyclin%20Dependent%20Kinase%201%20%28CDK1%29%20and%206%20%28CDK6%29%2C%20combined%20depletion%20of%20eEF2K%20and%204EBP1%20resulted%20in%20overlapping%20effects%20on%20the%20proteome%2C%20with%20the%20highest%20impact%20on%20the%20%5Cu2018Collagen%20containing%20extracellular%20matrix%5Cu2019%20pathway%20%28e.g.%20COL1A1%29%2C%20as%20well%20as%20the%20amino-acid%20transporter%2C%20SLC7A5%5C%2FLAT1%2C%20suggesting%20a%20regulatory%20loop%20via%20mTORC1.%20In%20addition%2C%20combined%20depletion%20of%20eEF2K%20and%204EBP1%20indirectly%20reduced%20the%20levels%20of%20IFN-dependent%20innate%20immune%20response-related%20factors.%20Thus%2C%20eEF2K%20inhibition%20triggers%20cell%20cycle%20arrest%5C%2Fdeath%20under%20unfavourable%20metabolic%20conditions%20such%20as%20Gln-starvation%5C%2FGLS1%20inhibition%20or%204EBP1%20depletion%2C%20uncovering%20new%20therapeutic%20avenues%20for%20TNBC%20and%20underscoring%20a%20pressing%20need%20for%20clinically%20relevant%20eEF2K%20inhibitors.%22%2C%22date%22%3A%222021-04-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-88816-1%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41598-021-88816-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-28T18%3A58%3A07Z%22%7D%7D%5D%7D
Ju, Y., Ben-David, Y., Rotin, D., & Zacksenhaus, E. (2021). Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells. Scientific Reports, 11(1), 9181. https://doi.org/10.1038/s41598-021-88816-1 Cite